Core Viewpoint - Kelyniam Global is set to present at the Life Sciences Virtual Investor Forum, highlighting its advancements in custom cranial implants and its strategic partnerships to enhance product offerings [1][4]. Company Overview - Kelyniam Global specializes in the rapid production of custom prosthetics using advanced medical-grade polymers and computer-aided design and manufacturing [5]. - The company develops, manufactures, and distributes custom cranial implants, working closely with surgeons, health systems, and payors to improve clinical and cost-of-care outcomes [5]. Event Details - The presentation will take place on September 18, 2025, at 10:00 EDT, with management available for one-on-one meetings on September 18 PM, 19, and 22 [1]. - The event will be interactive, allowing real-time questions from investors, and an archived webcast will be available for those unable to attend live [2]. Product and Market Position - Kelyniam is experiencing sales momentum and has product line enhancements, including the CustomizedBone implant licensed from Finceramica Spa of Italy, which offers osteointegrative benefits [4]. - The company aims to become a leader in regenerative options for U.S. surgeons, supported by its partnerships with Osteopore for the OsteoStrip and Osteoplug product lines [4].